3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
16
Lymphoid
16
Gastrointestinal
15
Thoracic
7
Plasma cell
4
Myeloid
4
Genitourinary
4
Breast
3
Other
2
Classical hematology
2
Sarcoma
1
Other solid neoplasm
1
Head & Neck
1
Gynecologic
1
Dermatologic
1
CNS
1
Conditions
Unspecified Adult Solid Tumor, Protocol Specific
299
Solid Tumors
184
Advanced Solid Tumors
168
Solid Tumor
152
Mesothelioma, Malignant
152
Mesothelioma
121
Advanced Solid Tumor
97
Carcinoma, Non-Small-Cell Lung
50
Retinoblastoma
48
Lung Neoplasms
37
Solid Tumor, Adult
36
Sarcoma
31
Ovarian Neoplasms
29
Neoplasms
27
Stomach Neoplasms
26
Carcinoma, Renal Cell
26
Small Cell Lung Carcinoma
25
Melanoma
25
Pancreatic Neoplasms
24
Breast Neoplasms
24
Unspecified Childhood Solid Tumor, Protocol Specific
23
Esophageal Neoplasms
21
Uterine Cervical Neoplasms
20
Solid Tumours
20
Solitary Fibrous Tumor, Pleural
19
Osteosarcoma
19
Colorectal Neoplasms
17
Neuroblastoma
16
Head and Neck Neoplasms
16
Carcinoma, Hepatocellular
16
Interventions
bemcentinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
COVID-19
×
Other solid neoplasm
×
Clear all
NCT06469138
2025-01-29
8479217
BerGenBio ASA
Phase 1
Completed
6 enrolled
17 charts